In a clinical trial of semaglutide injection for weight loss (Wegovy) in patients with T2DM and a BMI of 27 kg/m2 or more, hypoglycemia (defined as a plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
She Annette Bennett Chief Executive Officer Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a Bo Vaughan, MD, MSHA, CPI Medical Director Mimi Franzen Canada Chief Operations Officer Jeanette Weller EVP of Contracts and Budgets Caitlin Vining Controller CCRP Kelly Craighead, BS, RN, CCRC Regulatory Affairs Director Carly McLaughlin, PharmD Director of Pharmacy PharmD Lisa Smith, BSN, RN Director of Quality Assurance Joy Walker Director of Business Development Aundraya Bray, LCSW Clinical Operations Coordinator Shawn Mease, CCRC, NRP, CCEMT-P Director of Study Start-Up
after being heated for 10 min to a temperature between 42 C and 46 C, tissues experience cell necrosis
Healthier heart: Vitamin B12 helps regulate the levels of homocysteine in the blood, which is a factor that can contribute to heart disease